Providence Medical Technology has announced FDA clearance of the Cavux facet fixation system for a new indication in the treatment of cervical pseudarthrosis, according to a press release.
The Cavux facet fixation system (FFS) features an integrated cage and screw system to provide facet joint stabilization for the facilitation of spinal fusion. According to the release, the Cavux FFS is now indicated for the treatment of patients who require revision for anterior pseudarthrosis occurring at one level from C3-C7 with autogenous or allogenic bone graft.
“At Providence, our purpose is